Company: CERO
Filing Date: 2025-05-02
Form Type: PRER14A
Source: 0001213900-25-039149
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-02
Form: PRER14A
Chunk 3
---
ification of the appointment of Wolf & Company, P.C. (“Wolf”), as the Company’s independent registered public accounting firm for the 2025 fiscal year (the “Auditor Ratification Proposal” or “Proposal No. 6”); and 7.The approval of an adjournment of the Annual Meeting, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes in favor of Proposal Nos.1,2, 3 or 4 (the “Adjournment Proposal” or “Proposal No. 7”). The Board has fixed the record date for the Annual Meeting as March31, 2025. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment or postponement thereof. A complete list of the Company’s registered stockholders as of the close of business on the record date will be

available to the Company’s stockholders for examination for the ten days before the Annual Meeting at the Company’s offices at 201 Haskins Way, Suite 230, South San Francisco, CA 94080 and during the Annual Meeting at ht tps://www.cstproxy.com/cero/2025. You will be able to attend and listen to the Annual Meeting, vote, and submit your questions during the Annual Meeting by visiting https://www.cstproxy.com/cero/2025and entering your 16 -digitcontrol number included on your proxy card or on the instructions that accompanied your proxy materials. We believe that hosting a “virtual” meeting will minimize travel expenses and enable greater stockholder attendance and participation from any location around the world, provide for cost savings to the Company, and reduce the environmental impact of the Annual Meeting. The Annual Meeting will be governed by the Company’s rules of conduct and procedures that will be posted at h ttps://www.cstproxy.com/cero/202 5. Your vote is important.Whether or not you plan to virtually attend the Annual Meeting, we encourage you to vote as soon as possible to ensure that your shares are represented. Information about voting methods is set forth in the accompanying proxy statement. Each of the matters to be acted upon at the Annual Meeting is more fully described in the accompanying proxy statement. The Board recommends that you vote “ FOR” each of the proposals outlined in the accompanying proxy statement. The accompanying proxy statement is being mailed to stockholders commencing on or about, 2025. Please carefully review the accompanying proxy statement and act as soon